Role of dendritic cell‑derived exosomes in allergic rhinitis (Review).

allergic rhinitis dendritic cells exosomes extracellular vesicles intercellular communication

Journal

International journal of molecular medicine
ISSN: 1791-244X
Titre abrégé: Int J Mol Med
Pays: Greece
ID NLM: 9810955

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 03 08 2023
accepted: 11 10 2023
medline: 30 10 2023
pubmed: 27 10 2023
entrez: 27 10 2023
Statut: ppublish

Résumé

Allergic rhinitis (AR) is a common pathological condition in otorhinolaryngology. Its prevalence has been increasing worldwide and is becoming a major burden to the world population. Dendritic cells (DCs) are typically activated and matured after capturing, phagocytosing, and processing allergens during the immunopathogenesis of AR. In addition, the process of DC activation and maturation is accompanied by the production of exosomes, which are cell‑derived extracellular vesicles (EVs) that can carry proteins, lipids, nucleic acids, and other cargoes involved in intercellular communication and material transfer. In particular, DC‑derived exosomes (Dex) can participate in allergic immune responses, where the biological substances carried by them can have potentially important implications for both the pathogenesis and treatment of AR. Dex can also be exploited to carry anti‑allergy agents to effectively treat AR. This provides a novel method to explore the pathogenesis of and treatment strategies for AR further. Therefore, the present review focuses on the origin, composition, function, and biological characteristics of DCs, exosomes, and Dex, in addition to the possible relationship between Dex and AR.

Identifiants

pubmed: 37888754
doi: 10.3892/ijmm.2023.5320
pii: 117
pmc: PMC10635688
doi:
pii:

Substances chimiques

Allergens 0

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Traffic. 2021 Jul;22(7):204-220
pubmed: 34053166
Microbiol Spectr. 2016 Dec;4(6):
pubmed: 28087939
J Nanobiotechnology. 2021 Sep 08;19(1):271
pubmed: 34496871
J Extracell Vesicles. 2021 Apr;10(6):e12087
pubmed: 33936570
Int Rev Cell Mol Biol. 2019;349:213-249
pubmed: 31759432
Allergy. 2022 Nov;77(11):3309-3319
pubmed: 35892225
Exp Hematol Oncol. 2022 Jun 7;11(1):36
pubmed: 35672796
Cell Biosci. 2019 Feb 15;9:19
pubmed: 30815248
J Immunol. 2013 Mar 15;190(6):2712-9
pubmed: 23418627
Nucleic Acids Res. 2019 Jan 8;47(D1):D516-D519
pubmed: 30395310
Front Bioeng Biotechnol. 2022 Jan 05;9:811971
pubmed: 35071216
Cancers (Basel). 2021 Apr 01;13(7):
pubmed: 33915822
Biomed Pharmacother. 2022 Aug;152:113250
pubmed: 35700679
Nat Rev Immunol. 2014 Mar;14(3):195-208
pubmed: 24566916
J Immunol. 2014 Aug 1;193(3):1006-11
pubmed: 25049431
Mol Ther. 2006 Feb;13(2):289-300
pubmed: 16275099
Small. 2020 Mar;16(9):e1903916
pubmed: 31663295
Methods Mol Biol. 2007;380:443-55
pubmed: 17876111
J Exp Med. 2021 Aug 2;218(8):
pubmed: 34180950
Nat Rev Cancer. 2012 Mar 22;12(4):265-77
pubmed: 22437871
J Exp Med. 2019 Sep 2;216(9):1974-1985
pubmed: 31420375
Trends Immunol. 2011 Nov;32(11):540-7
pubmed: 21835696
Annu Rev Immunol. 2013;31:563-604
pubmed: 23516985
ACS Omega. 2022 Dec 09;7(50):46222-46233
pubmed: 36570199
Front Immunol. 2017 Jul 21;8:826
pubmed: 28785260
Immunol Cell Biol. 2020 Sep;98(8):639-649
pubmed: 32378751
Front Pharmacol. 2022 Dec 15;13:1096984
pubmed: 36588711
Biochim Biophys Acta Rev Cancer. 2019 Apr;1871(2):455-468
pubmed: 31047959
Allergy. 2015 Dec;70(12):1651-5
pubmed: 26198793
Biomed Res Int. 2018 May 8;2018:2862187
pubmed: 29854739
Front Immunol. 2020 May 21;11:924
pubmed: 32508825
Semin Cell Dev Biol. 2018 Dec;84:11-21
pubmed: 29246859
Acta Biomater. 2022 Jan 15;138:491-504
pubmed: 34757230
J Immunol. 2020 Feb 15;204(4):733-744
pubmed: 32015076
J Lipid Res. 2019 Jan;60(1):9-18
pubmed: 30076207
Mol Cancer. 2022 Nov 1;21(1):207
pubmed: 36320056
Prog Lipid Res. 2017 Apr;66:30-41
pubmed: 28342835
Nanoscale. 2021 Oct 14;13(39):16457-16464
pubmed: 34648610
J Immunol. 2013 Sep 15;191(6):2871-8
pubmed: 23945142
Front Immunol. 2018 Mar 19;9:455
pubmed: 29616018
Int J Mol Sci. 2015 Dec 24;17(1):
pubmed: 26712742
Biochem Biophys Res Commun. 2022 Sep 24;622:30-36
pubmed: 35843091
ACS Nano. 2015 Mar 24;9(3):2321-7
pubmed: 25672598
Mol Cancer. 2017 Aug 29;16(1):145
pubmed: 28851367
Semin Immunopathol. 2018 Sep;40(5):477-490
pubmed: 29594331
Cell Res. 2017 Jan;27(1):74-95
pubmed: 28025976
Nat Rev Dis Primers. 2020 Dec 3;6(1):95
pubmed: 33273461
Life Sci. 2021 Jan 1;264:118623
pubmed: 33096118
Immunol Cell Biol. 2020 Nov;98(10):807-818
pubmed: 32738152
J Clin Invest. 2016 Apr 1;126(4):1224-32
pubmed: 27035813
Theranostics. 2021 Jan 1;11(7):3183-3195
pubmed: 33537081
Nat Cell Biol. 2018 Mar;20(3):332-343
pubmed: 29459780
Int J Nanomedicine. 2021 Feb 17;16:1281-1312
pubmed: 33628021
Int J Med Sci. 2022 Jul 11;19(8):1265-1274
pubmed: 35928722
Nat Rev Immunol. 2015 Jan;15(1):18-29
pubmed: 25534620
Cells. 2019 Apr 03;8(4):
pubmed: 30987213
J Chromatogr Sci. 2020 Jul 24;58(7):636-640
pubmed: 32577740
Inflammation. 2013 Feb;36(1):232-40
pubmed: 22956173
Biosens Bioelectron. 2020 Jul 15;160:112213
pubmed: 32339150
Nat Immunol. 2018 Jul;19(7):652-654
pubmed: 29925994
Mol Cancer. 2018 Apr 20;17(1):82
pubmed: 29678180
Int J Mol Sci. 2023 Jan 10;24(2):
pubmed: 36674857
Biochim Biophys Acta. 2014 Aug;1846(1):75-87
pubmed: 24747178
J Immunol. 2007 Aug 15;179(4):2242-9
pubmed: 17675485
Ann Oncol. 2021 Apr;32(4):466-477
pubmed: 33548389
Vaccines (Basel). 2022 Jan 17;10(1):
pubmed: 35062793
Science. 2020 Feb 7;367(6478):
pubmed: 32029601
J Hematol Oncol. 2020 Nov 10;13(1):152
pubmed: 33168028
Sci Rep. 2018 Jul 9;8(1):10340
pubmed: 29985427
Theranostics. 2018 Jan 1;8(1):237-255
pubmed: 29290805
J Cell Commun Signal. 2019 Dec;13(4):443-450
pubmed: 31172413
Cancers (Basel). 2021 Jul 21;13(15):
pubmed: 34359569
ACS Biomater Sci Eng. 2021 Jun 14;7(6):2106-2149
pubmed: 33988964
Nat Rev Immunol. 2023 Apr;23(4):236-250
pubmed: 35927511
Cancers (Basel). 2019 Oct 14;11(10):
pubmed: 31615107
Front Immunol. 2022 Feb 15;13:731516
pubmed: 35242126
J Transl Med. 2021 Mar 9;19(1):103
pubmed: 33750417
Science. 2018 Nov 9;362(6415):
pubmed: 30409859
World Allergy Organ J. 2016 Feb 11;9:7
pubmed: 26904159
Mol Cancer. 2019 Jul 5;18(1):116
pubmed: 31277663
Mediators Inflamm. 2022 Jun 16;2022:4428617
pubmed: 35757106
Front Immunol. 2019 Mar 29;10:648
pubmed: 30984201
J Leukoc Biol. 2022 Apr;111(4):903-920
pubmed: 34699107
Pathobiology. 2019;86(2-3):111-117
pubmed: 30408778
Int Rev Immunol. 2022;41(1):30-44
pubmed: 34423733
Clin Chim Acta. 2019 Aug;495:139-147
pubmed: 30978325
Cell Mol Life Sci. 2018 Jan;75(2):193-208
pubmed: 28733901
Biomark Res. 2022 May 12;10(1):30
pubmed: 35550636
J Inflamm Res. 2022 May 31;15:3187-3205
pubmed: 35668915
Adv Sci (Weinh). 2022 May;9(15):e2103222
pubmed: 35332686
Stem Cell Res Ther. 2019 Aug 30;10(1):278
pubmed: 31470892
J Int Med Res. 2020 Feb;48(2):300060520903220
pubmed: 32096421
Blood Cells Mol Dis. 2005 Sep-Oct;35(2):89-93
pubmed: 15990342
Trends Biotechnol. 2020 Oct;38(10):1066-1098
pubmed: 32564882
Br J Pharmacol. 2023 Feb;180(3):330-346
pubmed: 36156794
Int J Mol Sci. 2019 May 01;20(9):
pubmed: 31052382
Cancer Res. 2010 Feb 15;70(4):1281-5
pubmed: 20145139
Mol Med Rep. 2021 Feb;23(2):
pubmed: 33313954
Annu Rev Physiol. 2016;78:67-83
pubmed: 26667071
Arthritis Rheum. 2009 Feb;60(2):380-9
pubmed: 19180475
Drug Des Devel Ther. 2023 Jul 19;17:2087-2106
pubmed: 37489176
Clin Exp Allergy. 2020 Mar;50(3):291-307
pubmed: 31925972
Mol Cancer. 2019 Mar 30;18(1):57
pubmed: 30925935
Immunity. 2008 Apr;28(4):490-2
pubmed: 18400192
Nat Methods. 2021 Feb;18(2):212-218
pubmed: 33432243
J Immunol. 2009 Jul 15;183(2):1074-82
pubmed: 19553531
Arch Pharm Res. 2022 May;45(5):295-308
pubmed: 35604532
Int Immunopharmacol. 2022 Dec;113(Pt B):109449
pubmed: 36403519
Cells. 2021 Dec 30;11(1):
pubmed: 35011677
Int J Mol Sci. 2021 Jul 21;22(15):
pubmed: 34360530
J Extracell Vesicles. 2018 Mar 04;7(1):1442985
pubmed: 29535851
PLoS One. 2009;4(3):e4942
pubmed: 19319200
Chem Rev. 2018 Feb 28;118(4):1917-1950
pubmed: 29384376
J Exp Clin Cancer Res. 2020 Nov 23;39(1):258
pubmed: 33228747
Open Biol. 2022 May;12(5):210317
pubmed: 35506205
Respirology. 2003 Jun;8(2):140-8
pubmed: 12753527
Expert Rev Anticancer Ther. 2005 Jun;5(3):537-47
pubmed: 16001959
Cell Mol Immunol. 2018 Nov;15(11):944-952
pubmed: 29578531
Front Immunol. 2021 Aug 19;12:702381
pubmed: 34489951
J Allergy Clin Immunol. 2010 Nov;126(5):1032-40, 1040.e1-4
pubmed: 20728205
Front Immunol. 2021 Mar 25;12:636222
pubmed: 33841418
Int J Nanomedicine. 2020 Sep 22;15:6917-6934
pubmed: 33061359
Int J Mol Sci. 2019 Jul 14;20(14):
pubmed: 31337156
Immunity. 2019 Jan 15;50(1):37-50
pubmed: 30650380
Immunology. 2018 May;154(1):3-20
pubmed: 29313948
Extracell Vesicles Circ Nucl Acids. 2021;2:127-147
pubmed: 34414402
Sci Transl Med. 2019 May 15;11(492):
pubmed: 31092696
Sci Rep. 2017 Dec 6;7(1):17095
pubmed: 29213052
J Hematol Oncol. 2020 Aug 3;13(1):107
pubmed: 32746880
Crit Rev Ther Drug Carrier Syst. 2021;38(5):53-97
pubmed: 34375513
Int Arch Allergy Immunol. 2016;171(1):1-26
pubmed: 27820941
Nat Cell Biol. 2021 Jun;23(6):631-641
pubmed: 34108659
Acta Pharm Sin B. 2021 Sep;11(9):2783-2797
pubmed: 34589397

Auteurs

Chenglin Kang (C)

Department of Graduate and Scientific Research, Zunyi Medical University Zhuhai Campus, Zhuhai, Guangdong 519041, P.R. China.

Haipeng He (H)

Department of Otolaryngology, Longgang ENT Hospital and Shenzhen Key Laboratory of ENT, Institute of ENT Shenzhen, Shenzhen, Guangdong 518172, P.R. China.

Peng Liu (P)

Department of Graduate and Scientific Research, Zunyi Medical University Zhuhai Campus, Zhuhai, Guangdong 519041, P.R. China.

Yue Liu (Y)

Department of Graduate and Scientific Research, Zunyi Medical University Zhuhai Campus, Zhuhai, Guangdong 519041, P.R. China.

Xiaomei Li (X)

Department of Otolaryngology, Second People's Hospital of Gansu Province, Lanzhou, Gansu 730000, P.R. China.

Jin Zhang (J)

Department of Graduate and Scientific Research, Zunyi Medical University Zhuhai Campus, Zhuhai, Guangdong 519041, P.R. China.

Hong Ran (H)

Department of Graduate and Scientific Research, Zunyi Medical University Zhuhai Campus, Zhuhai, Guangdong 519041, P.R. China.

Xianhai Zeng (X)

Department of Graduate and Scientific Research, Zunyi Medical University Zhuhai Campus, Zhuhai, Guangdong 519041, P.R. China.

Hailiang Zhao (H)

Department of Graduate and Scientific Research, Zunyi Medical University Zhuhai Campus, Zhuhai, Guangdong 519041, P.R. China.

Jiangqi Liu (J)

Department of Graduate and Scientific Research, Zunyi Medical University Zhuhai Campus, Zhuhai, Guangdong 519041, P.R. China.

Shuqi Qiu (S)

Department of Graduate and Scientific Research, Zunyi Medical University Zhuhai Campus, Zhuhai, Guangdong 519041, P.R. China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH